About IncepBio
IncepBio is a company based in Bengaluru (India) founded in 2016. The company has 53 employees. IncepBio offers products and services including Thermal Validation and CQV Services.
- Headquarter Bengaluru, India
- Employees 53
- SectorsHealthcare
- Email••••••••
- Social LinkedIn X Facebook YouTube
- Legal Name Incepbio Private Limited
- Date of Incorporation 10 Jun, 2016
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹12.06 Cr
FY 2025 · -1% YoY
- Net Profit₹13.1 Lakh
FY 2025 · 1% margin
- EBITDA₹95.9 Lakh
FY 2025 · 8% margin
- Employee Count53
Associated legal entities of IncepBio
IncepBio operates through Incepbio Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Incepbio Private Limited CIN U24304KA2016PTC094041 | Active | 10 Jun 2016 | Bangalore, Karnataka | ₹12.1 Cr | 53 | 3 | View details |
Products & Services of IncepBio
IncepBio offers a comprehensive portfolio of products and services, including Thermal Validation and CQV Services.
Temperature control is ensured for quality-sensitive processes in pharmaceuticals.
Equipment and systems are validated to meet pharmaceutical standards.
Apps and channels of IncepBio
its YouTube channel Incepbio has 14 subscribers and 5 videos.
Videos from IncepBio
The most watched videos on IncepBio's YouTube channel, Incepbio (14 subscribers). Click a video to play it here.
More on Incepbio.
Board of directors of Incepbio Private Limited (IncepBio)
Incepbio Private Limited is the primary company behind IncepBio. The board of Incepbio Private Limited currently have 3 directors; the longest-serving is Ambarish Ghali, appointed in 2016. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ambarish Ghali DIN 07228961 | Director | 10 Jun 2016 | 10 yrs 4 mo | Incepbio Private Limited |
| Subasha Hugar Prashanth DIN 07225583 | Director | 10 Jun 2016 | 10 yrs 4 mo | Incepbio Private Limited |
| Samit Deb DIN 07657179 | Director | 30 Nov 2016 | 9 yrs 10 mo | Incepbio Private Limited |
Financials of IncepBio
Figures of Incepbio Private Limited, the primary company behind IncepBio, for FY 2025. Revenue was ₹12.06 Cr (-1% year on year). Net profit was ₹13.1 Lakh (1% margin). EBITDA was ₹95.9 Lakh (8% margin). Revenue has grown at a compounded annual rate of +35% over three years and +12% over five years.
- ₹12.06 CrRevenue · FY 2025 · -1% YoY
- ₹13.1 LakhNet profit · 1% margin
- ₹95.9 LakhEBITDA · 8% margin
- ₹2.8 LakhPaid-up capital
- 53Employees (provident fund records)
- +35%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Incepbio Private Limited are on its company page.
Detailed financial statements for IncepBio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to IncepBio
10 companies that operate in the same segment as IncepBio (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IncepBio
IncepBio was founded in 2016.
IncepBio is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
IncepBio has 53 employees.
The primary company behind IncepBio, Incepbio Private Limited, reported revenue of ₹12.06 Cr for FY 2025, down 1% year on year.
IncepBio Private Limited was established in 2016 to support pharmaceutical companies in achieving regulatory compliance and quality assurance through services like CQV, thermal validation, and cleanroom validation. With over 50 years of combined experience, integrated solutions are offered to more than 100 clients, ensuring adherence to ISO 9001:2015 standards. Flexibility and customer-centric approaches are emphasized, while innovation is driven to meet evolving industry needs and regulatory requirements, fostering reliable and efficient operations.
IncepBio offers Thermal Validation and CQV Services.
IncepBio operates through Incepbio Private Limited.
The legal entities of IncepBio currently have 3 directors, including Ambarish Ghali, Subasha Hugar Prashanth, Samit Deb.